13F-NT filed by Bain Capital Life Sciences Opportunities III, LP
Bain Capital Life Sciences Opportunities III, LP filed this 13F-NT for the quarter ended 2022-12-31, filed 2023-02-14.
- Accession
- 0000950123-23-002144
- Filer
- CIK 1950105
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A notice, 13F file number 028-22966. A notice: the holdings are in another manager's report. The resolved quarter.
Other managers
- reports for this filerBain Capital Life Sciences Investors, LLC 028-18477
- reports for this filerBain Capital Life Sciences III General Partner, LLC
- reports for this filerBain Capital Life Sciences Fund III, L.P.
- reports for this filerBain Capital Life Sciences Opportunities III GP, LLC
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-NT 0000950123-23-002144 | this filing | 2023-02-14 | acceptance time not in the bulk data set |